% alzhub.org library filter
% Source: https://alzhub.org/research?author=Donohue+MC&score_min=67
% 14 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{papp2024-39044493,
  author  = {Papp, K. V. and Maruff, P. and Rentz, D. M. and Donohue, M. C. and Liu, A. and Aisen, P. S. and Sperling, R. A.},
  title   = {{Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 Study}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2024},
  doi     = {10.14283/jpad.2024.137},
  pmid    = {39044493},
  url     = {https://doi.org/10.14283/jpad.2024.137}
}

@article{bateman2023-37966285,
  author  = {Bateman, R. J. and Smith, J. and Donohue, M. C. and Delmar, P. and Abbas, R. and Salloway, S. and Wojtowicz, J. and Blennow, K. and others},
  title   = {{Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2023},
  doi     = {10.1056/nejmoa2304430},
  pmid    = {37966285},
  url     = {https://doi.org/10.1056/nejmoa2304430}
}

@article{sperling2023-37458272,
  author  = {Sperling, R. A. and Donohue, M. C. and Raman, R. and Rafii, M. S. and Johnson, K. and Masters, C. L. and van Dyck, C. H. and Iwatsubo, T. and others},
  title   = {{Trial of Solanezumab in Preclinical Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2023},
  doi     = {10.1056/nejmoa2305032},
  pmid    = {37458272},
  url     = {https://doi.org/10.1056/nejmoa2305032}
}

@article{shirzadi2024-39044495,
  author  = {Shirzadi, Z. and Schultz, A. P. and Properzi, M. and Yaari, R. and Yau, W. W. and Brickman, A. M. and Rafii, M. S. and Donohue, M. C. and others},
  title   = {{Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's Disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2024},
  doi     = {10.14283/jpad.2024.139},
  pmid    = {39044495},
  url     = {https://doi.org/10.14283/jpad.2024.139}
}

@article{craft2020-32568367,
  author  = {Craft, S. and Raman, R. and Chow, T. W. and Rafii, M. S. and Sun, C. K. and Rissman, R. A. and Donohue, M. C. and Brewer, J. B. and others},
  title   = {{Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2020.1840},
  pmid    = {32568367},
  url     = {https://doi.org/10.1001/jamaneurol.2020.1840}
}

@article{sperling2024-39044488,
  author  = {Sperling, R. A. and Donohue, M. C. and Rissman, R. A. and Johnson, K. A. and Rentz, D. M. and Grill, J. D. and Heidebrink, J. L. and Jenkins, C. and others},
  title   = {{Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2024},
  doi     = {10.14283/jpad.2024.122},
  pmid    = {39044488},
  url     = {https://doi.org/10.14283/jpad.2024.122}
}

@article{grill2020-32777010,
  author  = {Grill, J. D. and Raman, R. and Ernstrom, K. and Sultzer, D. L. and Burns, J. M. and Donohue, M. C. and Johnson, K. A. and Aisen, P. S. and others},
  title   = {{Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2020.2734},
  pmid    = {32777010},
  url     = {https://doi.org/10.1001/jamaneurol.2020.2734}
}

@article{sperling2021-33464300,
  author  = {Sperling, R. and Henley, D. and Aisen, P. S. and Raman, R. and Donohue, M. C. and Ernstrom, K. and Rafii, M. S. and Streffer, J. and others},
  title   = {{Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2021},
  doi     = {10.1001/jamaneurol.2020.4857},
  pmid    = {33464300},
  url     = {https://doi.org/10.1001/jamaneurol.2020.4857}
}

@article{donohue2017-28609533,
  author  = {Donohue, M. C. and Sperling, R. A. and Petersen, R. and Sun, C. K. and Weiner, M. W. and Aisen, P. S. and {Alzheimer’s Disease Neuroimaging Initiative}},
  title   = {{Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons}},
  journal = {JAMA},
  year    = {2017},
  doi     = {10.1001/jama.2017.6669},
  pmid    = {28609533},
  url     = {https://doi.org/10.1001/jama.2017.6669}
}

@article{insel2025-40853684,
  author  = {Insel, P. S. and Mattsson-Carlgren, N. and Langford, O. and Caruso, V. M. and Leuzy, A. and Young, C. B. and Boxer, A. and Aisen, P. S. and Sperling, R. A. and Mormino, E. C. and Donohue, M. C.},
  title   = {{Concurrent Changes in Plasma Phosphorylated Tau 217, Tau PET, and Cognition in Preclinical Alzheimer Disease}},
  journal = {JAMA Neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.2974},
  pmid    = {40853684},
  url     = {https://doi.org/10.1001/jamaneurol.2025.2974}
}

@article{sperling2020-32250387,
  author  = {Sperling, R. A. and Donohue, M. C. and Raman, R. and Sun, C. K. and Yaari, R. and Holdridge, K. and Siemers, E. and Johnson, K. A. and others},
  title   = {{Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2020.0387},
  pmid    = {32250387},
  url     = {https://doi.org/10.1001/jamaneurol.2020.0387}
}

@article{dubbelman2025-40440591,
  author  = {Dubbelman, M. A. and Liu, A. and Donohue, M. C. and Langford, O. and Raman, R. and Rentz, D. M. and Amariglio, R. and Sperling, R. A. and others},
  title   = {{Changes in Daily Functioning in Association With Tau and Amyloid Among Unimpaired Older Adults With and Without Elevated Amyloid}},
  journal = {Neurology},
  year    = {2025},
  doi     = {10.1212/wnl.0000000000213775},
  pmid    = {40440591},
  url     = {https://doi.org/10.1212/wnl.0000000000213775}
}

@article{petersen2010-20042704,
  author  = {Petersen, R. C. and Aisen, P. S. and Beckett, L. A. and Donohue, M. C. and Gamst, A. C. and Harvey, D. J. and Jack, C. R. and Jagust, W. J. and others},
  title   = {{Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization}},
  journal = {Neurology},
  year    = {2010},
  doi     = {10.1212/wnl.0b013e3181cb3e25},
  pmid    = {20042704},
  url     = {https://doi.org/10.1212/wnl.0b013e3181cb3e25}
}

@article{insel2023-35962782,
  author  = {Insel, P. S. and Young, C. B. and Aisen, P. S. and Johnson, K. A. and Sperling, R. A. and Mormino, E. C. and Donohue, M. C.},
  title   = {{Tau positron emission tomography in preclinical Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2023},
  doi     = {10.1093/brain/awac299},
  pmid    = {35962782},
  url     = {https://doi.org/10.1093/brain/awac299}
}